UK’s stem cell transplant system may be putting lives at risk, report by MPs finds
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- All‑party parliamentary group on ethnicity transplantation and transfusion released a report stating the UK's stem cell transplant system is “no longer resilient, sustainable nor equitable” and fails to meet patients’ needs.
- UK stem cell transplants in 2024‑25 used only 24% of UK donors, far below the 45% target identified by the UK Stem Cell Strategic Forum, increasing reliance on costlier overseas donations.
- Minority‑ethnic patients have a 37% chance of finding a well‑matched donor versus a 72% chance for white patients of northern European background, highlighting stark health inequities.
- UK stem cell donation oversight lacks a single organization responsible for stem cell donations, unlike blood and organ donation systems, leading to slower, fragmented policy changes.
- Bell Ribeiro‑Addy (Labour MP and APPG chair) called for a government review, noting gaps in accountability, planning, fairness, and incomplete data on patients missing out on transplants.
- Department for Health and Social Care announced a comprehensive review of the current system to improve UK‑based donation and address unequal access.
Why it matters: Blood‑cancer patients, especially those from minority backgrounds, lose timely access to life‑saving transplants as the system relies on costly overseas donors and lacks coordinated oversight; a government review could improve domestic donor recruitment and equity, benefiting patients and reducing costs.
Ask SkimNews
